8.7-NavigatingTheAdverseEffectsOfADT

August 7, 2017/by CURC

/wp-content/uploads/logo-1.png 0 0 CURC /wp-content/uploads/logo-1.png CURC2017-08-07 15:27:152017-08-07 15:27:158.7-NavigatingTheAdverseEffectsOfADT

Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
Comparison of Germline Mutations In African American And Caucasian Men With Metastatic Prostate Cancer
Niraparib With Androgen Receptor-Axis-Targeted Therapy In Patients With Metastatic Castration-Resistant Prostate Cancer: Safety And Pharmacokinetic Results From A Phase 1b Study (BEDIVERE)
Combined Advanced Prostate Cancer Treatments- Are They Additive?
Treatment of Nonmetastatic Castration- Resistant Prostate Cancer: Focus On Second-Generation Androgen Receptor Inhibitors
Treating The Patient And Not Just The Cancer: Therapeutic Burden In Prostate Cancer

Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572

Phone: (843) 839-1679
Fax: (843) 286-0119

Email:
info@curcmb.com

Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
Comparison of Germline Mutations In African American And Caucasian Men With Metastatic Prostate Cancer